GENEVA, Oct. 9 -- KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY filed a patent application (KR2026/095428) for “ANTIBODY-DRUG CONJUGATE COMPRISING NOVEL NUTMEG-DERIVED COMPOUND AND ANTIBODY-LIKE PROTEIN”. With publication no. WO/2026/212442, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....